New Vistas in Prostate Cancer Imaging
New Vistas in Prostate Cancer Imaging is organized by Meetings By Mail, Global Education Group
Release date: May 1, 2022
Expiration date: April 30, 2025
Overview:
As the need to identify and treat prostate cancer increases, imaging is a critical tool in its diagnosis, staging and surveillance. This activity analyzes the two most promising imaging modalities for prostate cancer: multiparametric MRI and PSMA PET/CT. Essential concepts and multiple cases in both modalities are reviewed throughout the course, ensuring the audience a well rounded primer in the visualization and examination of this disease.
Learning Objectives:
After completing this activity, the participant should be better able to:
• Describe state of the art mpMRI and molecular imaging techniques for detection, staging and surveillance of prostate cancer.
• Discuss the utility of MRI fusion biopsy and in-bore biopsy in the detection of prostate cancer.
• Develop a successful community based prostate imaging practice based on reliable high quality imaging with PIRADS Lexicon and multidisciplinary communication.
• Describe novel theranostic therapies for the treatment of prostate cancer.
• Review new molecular imaging acquisition and interpretation techniques for optimal prostate imaging.
• Discuss the physiologic basis of PSMA therapy.
• Discuss how radiogenomics will alter the future landscape of prostate cancer.
Topics:
• PI-RADS
• targeted biopsy
• staging
• controversies
• Axumin
• PET-C11 Choline
• community challenges
• plus more than 25 prostate cancer cases analyzing the use of mpMRI and PSMA PET/CT.